Overview
What is Cll Global Research Foundation C/O William Wierda?
The Cll Global Research Foundation C/O William Wierda is a nonprofit organization primarily focused on accelerating research in the field of chronic lymphocytic leukemia (CLL). With a mission to eliminate CLL as a health threat, they grant funds to support innovative, patient-oriented concepts in areas such as monoclonal antibodies, prognostic factors, vaccines, gene therapy, and drug development. The organization follows a rigorous submission, evaluation, and funding process, guided by a Scientific Advisory Board composed of experienced CLL specialists. In addition, the foundation supports postdoctoral fellows conducting CLL-specific research projects. In 2022, Cll Global awarded new grants ranging from $100,000 to $250,000. Their headquarters is located in Houston, Texas.
Official website here: www.cllglobal.org
Is Cll Global Research Foundation C/O William Wierda legitimate?
Cll Global Research Foundation C/O William Wierda is a legitimate nonprofit organization registered as a 501(c)(3) entity. Cll Global Research Foundation C/O William Wierda submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $40,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $30,000
For more financial information, click here
What is the mission statement of Cll Global Research Foundation C/O William Wierda?
The CLL Global Research Foundation aims to eradicate chronic lymphocytic leukemia (CLL) as a significant health threat to patients. They accomplish this mission by expediting CLL research, focusing on promising, lesser-explored areas. The organization provides research grants through various mechanisms, funding the world's top CLL science. Their Scientific Advisory Board (SAB) determines research priorities and oversees the grant application process. The SAB is comprised of experts in CLL treatment, drug development, and disease research. CLL Global also supports postdoctoral fellows conducting CLL-specific projects. In 2022, they granted new research projects ranging from $100,000 to $250,000, with the possibility of extending funding based on progress.
Official website here: www.cllglobal.org
Who is the CEO of Cll Global Research Foundation C/O William Wierda?
Dr William Wierda is the Founding Director of Cll Global Research Foundation C/O William Wierda. The CEO's salary of Cll Global Research Foundation C/O William Wierda is $14,531 and their total compensation is $14,531.
Official website here: www.cllglobal.org
What is the revenue of Cll Global Research Foundation C/O William Wierda?
Cll Global Research Foundation C/O William Wierda's revenue in 2022 was $1,719,451.
Official website here: www.cllglobal.org
Who are the executives of Cll Global Research Foundation C/O William Wierda and what are their salaries?
- Sam Margaret Pace (Cdo)
- William Wierda (President & Ceo) [Trustee/Director]
- Michael J Keating (Founding Director)
- Phyllis Cohen (Director)
- Louis Katopodis (Director)
- Diane Lee Kraitman (Director)
- Richard Marschner (Director)
- Robert Nichols (Director)
- William Plunkett (Director)
- Martin Raber (Director)
- Steve Winfield (Director)
Official website here: www.cllglobal.org
Where can I find the form 990 for Cll Global Research Foundation C/O William Wierda?
The Cll Global Research Foundation C/O William Wierda’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.cllglobal.org
Learn more at the official website: www.cllglobal.org
Mission Statement of Cll Global Research Foundation C/O William Wierda
The CLL Global Research Foundation, spearheaded by William Wierda, is committed to expediting the control and eventual eradication of chronic lymphocytic leukemia (CLL). Their mission is centered around abolishing CLL as a persistent danger to patients' lives and health by bolstering research efforts in this area. The foundation aims to propel progress in promising, yet untapped, research fields related to CLL, including monoclonal antibodies, prognostic factors, vaccines, gene therapy, and drug development. By funding the best CLL research worldwide, the CLL Global Research Foundation seeks to advance our understanding of the disease and develop more effective treatments for patients.
A dedicated Scientific Advisory Board (SAB) plays a crucial role in this mission. The SAB, comprised of seasoned experts in CLL treatment, drug development, and disease research, helps shape the foundation's research priorities and oversee the grant application process. This meticulous evaluation ensures that only the most promising and patient-focused concepts receive funding. Additionally, the foundation supports postdoctoral fellows engaged in CLL-specific research projects through its grant program. In 2022, the CLL Global Research Foundation awarded new research and individual grants ranging from $100,000 to $250,000, signaling its commitment to funding the best CLL science globally.
Impact
This information is meant to be a general summary of Cll Global Research Foundation C/O William Wierda. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
Cll Global Research Foundation, under the leadership of William Wierda, is actively working to accelerate progress toward the control and cure of chronic lymphocytic leukemia (CLL). Through research grants, the foundation focuses on funding novel and patient-oriented concepts in areas such as monoclonal antibodies, prognostic factors, vaccines & gene therapy, CLL survival pathway, genetics, molecular targets, and drug development. The Scientific Advisory Board, comprised of experts in the field, guides the research priorities and funding processes to ensure that the best CLL science globally is supported. In 2022, CLL Global awarded new research grants ranging from $100,000-$250,000, indicating a significant commitment to driving impactful research in the fight against CLL.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2003
Phone
(713) 745-2376
Principal Officer
Dr William Wierda
Main Address
1515 Holcombe Blvd Unit 428, Houston, TX, 77030
Website
www.cllglobal.org
NTEE Category
Code: H30 - Medical research
If you are a representative of Cll Global Research Foundation C/O William Wierda and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.